Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase II, Randomized, Placebo-controlled, Double-blind, Multiple Dose Study to Evaluate the Efficacy and Safety of ANB019 in Subjects With Palmoplantar Pustulosis

Trial Profile

A Phase II, Randomized, Placebo-controlled, Double-blind, Multiple Dose Study to Evaluate the Efficacy and Safety of ANB019 in Subjects With Palmoplantar Pustulosis

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 23 Aug 2018

At a glance

  • Drugs ANB 019 (Primary)
  • Indications Palmoplantar pustulosis
  • Focus Therapeutic Use
  • Acronyms POPLAR
  • Sponsors AnaptysBio
  • Most Recent Events

    • 13 Aug 2018 Status changed from planning to not yet recruiting.
    • 07 Aug 2018 According to an AnaptysBio media release, top line data from this study is anticipated in the second half of 2019.
    • 19 May 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top